HBK Sorce Advisory LLC Acquires New Position in HCA Healthcare, Inc. $HCA

HBK Sorce Advisory LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,267 shares of the company’s stock, valued at approximately $540,000.

Several other hedge funds have also recently modified their holdings of HCA. Saudi Central Bank purchased a new stake in shares of HCA Healthcare during the first quarter valued at $26,000. WPG Advisers LLC purchased a new stake in shares of HCA Healthcare during the 1st quarter valued at about $27,000. Ameriflex Group Inc. purchased a new position in shares of HCA Healthcare during the second quarter valued at approximately $27,000. Chung Wu Investment Group LLC bought a new stake in HCA Healthcare in the 2nd quarter worth approximately $27,000. Finally, Clearstead Trust LLC lifted its holdings in shares of HCA Healthcare by 311.8% during the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after buying an additional 53 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Stock Up 0.0%

NYSE:HCA opened at $474.06 on Friday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $520.00. The business’s 50-day simple moving average is $474.62 and its two-hundred day simple moving average is $419.32. The stock has a market cap of $108.18 billion, a PE ratio of 18.32, a P/E/G ratio of 1.40 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter last year, the company earned $4.90 EPS. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be paid a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is presently 11.13%.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Oppenheimer increased their target price on HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a report on Monday, October 27th. Wall Street Zen raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 25th. Cowen reiterated a “buy” rating on shares of HCA Healthcare in a research report on Monday, October 27th. Morgan Stanley lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price objective for the company. in a research note on Monday, December 15th. Finally, Truist Financial boosted their price target on HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a report on Monday, October 27th. Fourteen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $479.00.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.